BusinessElite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence StudyBy Nasdaq OMXMay 30, 2017, 12:55 PM UTC
BusinessElite Announces Development and License Agreement with SunGen Pharma LLCBy Nasdaq OMXAug 29, 2016, 12:00 PM UTC